Edition:
India

People: Cyanotech Corp (CYAN.OQ)

CYAN.OQ on NASDAQ Stock Exchange Capital Market

3.22USD
21 May 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.22
Open
$3.10
Day's High
$3.10
Day's Low
$3.10
Volume
60
Avg. Vol
1,103
52-wk High
$4.20
52-wk Low
$3.00

Katz, Nancy 

Ms. Nancy E. Katz serves as Independent Director of the Company. Ms. Katz served as Vice President, Consumer Marketing at Medtronic, Inc., a medical technology company, from May 2011 to August 2014. From July 2005 to July 2010, Ms. Katz was Senior Vice President, Bayer Diabetes Care — North America. Prior to this position, she was President and Chief Executive Officer of Calypte Biomedical Corporation, a manufacturer of HIV diagnostics, President of Zila Pharmaceutical, Inc., a manufacturer of oral care products, and held senior marketing positions with the Lifescan division of Johnson & Johnson (blood glucose diabetes products), Schering-Plough Healthcare Products, and with American Home Products. Ms. Katz has previously served on the Boards of Directors of Neoprobe Corporation, Calypte Biomedical Corporation, LXN Corporation and Pepgen Corporation. Ms. Katz currently serves on the Board of NeuroMetrix, Inc. Ms. Katz received a B.S. in business from the University of South Florida. Ms. Katz has significant experience as an executive and director of public companies and provides valuable insight to the Board and management in strategy development and other Company functions. Ms. Katz is a member of the Audit Committee and the Nominating and Corporate Governance Committee.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --